What we seem to forget from time to time
Dr. Jay: "So I never forget for a day how urgent this is to prospectively show our signal, bring a partner on board, and launch the kind of studies that'll bring an FDA approval as quickly as possible."
Dr. Jay: "I don't imagine that CytoDyn will ever commercialize the drug ourselves. What I imagine is when we confirm this PD-L1 induction, that the conversations we're currently having with a variety of potential industry partners will rapidly mature. And once we prospectively confirm the signal that we've seen retrospectively, that we'll be able to bring on the kind of partner that will be able to fund the phase three studies, including dose escalation studies that are necessary to get FDA approval."
Anyone who thinks CytoDyn will commercialize Leronlimab independently hasn't been listening.
Dr. Jay: "So I never forget for a day how urgent this is to prospectively show our signal, bring a partner on board, and launch the kind of studies that'll bring an FDA approval as quickly as possible."
Dr. Jay: "I don't imagine that CytoDyn will ever commercialize the drug ourselves. What I imagine is when we confirm this PD-L1 induction, that the conversations we're currently having with a variety of potential industry partners will rapidly mature. And once we prospectively confirm the signal that we've seen retrospectively, that we'll be able to bring on the kind of partner that will be able to fund the phase three studies, including dose escalation studies that are necessary to get FDA approval."
Anyone who thinks CytoDyn will commercialize Leronlimab independently hasn't been listening.
22
